BioSpecifics Technologies Corporation (BSTC)
Add to Watchlists Create an AlertBSTC Key Stats
| Income Statement | |
| Revenue TTM | 12.54M |
| Revenue Quarterly YoY Growth | 53.86% |
| EPS Diluted TTM | 0.518 |
| EPS Diluted Quarterly YoY Growth | 72.73% |
| Net Income TTM | 3.592M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | 34.00% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 100.29M |
| Enterprise Value | 88.08M |
| PE Ratio TTM | 30.49 |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 5.383 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | |
| Return on Equity | 21.23% |
BSTC News
- BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Fin... May 20
- Company News for May 13, 2013 May 13
- Company News for May 13, 2013 - Corporate Summary Zacks May 13
- BioSpecifics Technologies' Management Discusses Q1 2013 Results - Earnings Call ... May 10
- BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Fin... May 10
- BioSpecifics Technologies Corp. Reports First Quarter 2013 Financial Results PR Newswire May 10
- Q1 2013 Biospecifics Technologies Earnings Release - Time Not Supplied May 10
- BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report May 10
- BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter ... May 3
- BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Fin... Apr 18
BSTC Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). BioSpecifics Technologies Corporation is down 3.72% over the last year vs S&P 500 Total Return up 27.77%, Auxilium Pharmaceuticals down 20.52%, and Progenics Pharmaceuticals down 48.83%.
BSTC Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these BSTC related companies
Pro Ratings for BSTC
Pro Report PDF for BSTC
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download BSTC Pro Report PDF
Pro Strategies Featuring BSTC
Did BioSpecifics Technologies Corporation make it into our Pro Portfolio Strategies?
BSTC Profile
Sector: Healthcare
Industry: Biotechnology
Other BSTC Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BSTC | 15.79 | -0.08 | -0.50% | 100.29M |
